key: cord-0940289-ndlcj6d8
authors: Amat-Santos, Ignacio J.; Santos-Martinez, Sandra; López-Otero, Diego; Delgado-Arana, Jose Raúl; San Román, J. Alberto
title: Reply: ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
date: 2020-10-27
journal: J Am Coll Cardiol
DOI: 10.1016/j.jacc.2020.08.064
sha: c5b9d11e13e88be55cbe5061bc7dd620be18bb7e
doc_id: 940289
cord_uid: ndlcj6d8

nan

In response to the letter from Dr. Wang and colleagues, we thank them for the opportunity to further discuss our paper regarding the impact of randomized administration of ramipril on coronavirus disease 2019 (COVID-19) risk. The main motivation to perform this interim analysis of the RASTAVI (Reninangiotensin system blockade benefits in clinical outcomes and ventricular remodeling after transcatheter aortic valve implantation) trial was the concern that a simple retrospective analysis of this currently poorly known disease seemed to wipe out the well-known benefits of renin-angiotensin-aldosterone system (RAAS) inhibitors in various clinical settings (1) . We believe that the clinical urge should not lead to "sci- 

Ramipril in highrisk patients with COVID-19

Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Association of inpatient use of angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19

The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Florian Rader, MD, MSc, served as Guest Editor for this paper. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.